Company / Cost of Revenue
BIOADAPTIVES, INC. Cost of Revenue History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$5.8K
FY2025
5-year range
$5.8K / $17.7K
FY2021-FY2025
Trend
-33.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cost of Revenue has fluctuated over the past 7 years, ranging from $5,049 in FY2019 to $17,746 in FY2023.
Based on SEC 10-K filings.
$5,781 in FY2025 with a 5-year CAGR of -10.8%.
Improved from $17,746 to $5,781 over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -16.8%
- 5-Year CAGR
- -10.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -10.8%, indicating a declining trend.
- In FY2025, cost of revenue decreased 33.1% year-over-year.
- Peak cost of revenue was recorded in FY2023.
- Lowest cost of revenue in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -61.64 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.8K | -33.1% |
| FY2024 | $8.6K | -51.3% |
| FY2023 | $17.7K | +76.6% |
| FY2022 | $10.1K | +3.9% |
| FY2021 | $9.7K | -5.5% |
| FY2020 | $10.2K | +102.7% |
| FY2019 | $5.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026